This website uses cookies to ensure you get the best experience on our website. Privacy Policy
UroToday UroToday
  • Contact
  • Login
  • Sign Up Free
  • Transformative Evidence
    • mCRPC
      • The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
      • PROfound
      • VISION Trial
    • mHSPC
      • ARASENS Trial
    • nmCRPC
      • ARAMIS Trial
    • PSMA PET Imaging
      • CONDOR Trial
      • OSPREY Trial
    • Bladder Cancer
      • Bladder Cancer Detection
  • Trials in Progress
    • Trials in Progress
      • Bladder Cancer
        • IMMORTAL
      • Kidney Cancer
        • RadiCal
    • Middle Side
      • Prostate Cancer
        • ARAMON
        • ARASEC
        • ARASTEP
        • ECLIPSE
        • FORT
        • NRG-GU 0101
        • Masofaniten (Oral EPI-7386)
        • RTIRE
        • SHORTER
        • SPLASH
    • Right Side
      • PCCTC
        • DORA
        • IRONMAN
        • PROMISE
  • Centers of Excellence
    • Urologic Oncology
      • Left Group
        • Health Policy
          • Health Policy
            Ruchika Talwar, MD
        • Bladder Cancer
          • Bladder Cancer
            Ashish Kamat, MD
          • Advanced Bladder Cancer
            Petros Grivas, MD
          • Trimodality Therapy
            Leslie Ballas, MD
        • Kidney Cancer
          • Advanced Kidney Cancer
            Pedro Barata, MD, MSc
          • Kidney Cancer Today
            Sumanta (Monty) Kumar Pal, MD
            Jaime Landman, MD
      • Prostate Cancer
        • Advanced Prostate Cancer
          Alicia Morgans, MD, MPH
        • CRPC with Bone Metastases
          Rana R. McKay, MD
        • Imaging Center
          Phillip Koo, MD
        • Localized Prostate Cancer
          Matthew R. Cooperberg, MD, MPH
        • mHSPC
          Alicia Morgans, MD, MPH
        • nmCRPC
          Alicia Morgans, MD, MPH
        • PSMA-Targeted Therapy
      • Disparities: Social Determinants of Health
        • Disparities: Social Determinants of Health
          Samuel L. Washington III, MD, MAS
      • Translational Prostate Cancer
        • Translational Science in Prostate Cancer
          Andrea Miyahira, Ph.D
        • Women in Science
          Andrea Miyahira, Ph.D
      • Upper Tract Urothelial Carcinoma
        • Upper Tract Urothelial Carcinoma
          Sam S. Chang, MD, MBA
      • TESTICULAR, PENILE & RARE GU MALIGNANCIES
        • Testicular, Penile, and Rare GU Malignancies
    • Pelvic Health & Reconstruction
      • Bladder Health
        Diane K. Newman, DNP, ANP-BC, FAAN
      • Pelvic Health
        Diane K. Newman, DNP, ANP-BC, FAAN
      • Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
        Stephen R. Kraus, MD
      • Urologic Catheters (Includes CAUTI)
        Diane K. Newman, DNP, ANP-BC, FAAN
      • Suprapubic Catheter
        Diane K. Newman, DNP FAAN BCB-PMD
  • Videos
    • Exclusives
      • Conferences
      • Exclusive Collaborations
      • Independent Medical Education
      • Covid-19
      • The Prostate Cancer Foundation
    • Urologic Oncology
      • Prostate Cancer
      • Bladder Cancer
      • Kidney Cancer
      • Upper Tract Urothelial Tumors
      • Pelvic Health & Reconstruction
      • Endourology
      • Testicular Cancer
      • Health Policy in Urological Diseases
      • Disparities: Social Determinants of Health
  • Clinical Trials
    • From the Editor
      • Search Clinical Trials
  • Articles
    • Urology (benign and malignant)
      • Urologic Oncology
      • Men's Health
      • Endourology & Stones
      • Pediatric Urology
      • COVID-19 and Genitourinary Cancers
    • Pelvic Health
      • Pelvic Health & Reconstruction
  • Conference Coverage
    • Recent Conferences
      • ASTRO 2023
      • SNMMI 2023
      • ProsTIC/PCF Global Webinar 2023
      • ASCO 2023
      • AUA 2023
    • All Conferences
      • View All
  • PCF
  1. UroToday Home
  2. Recent Abstracts
  3. Urologic Oncology
  4. Prostate Cancer

Conferences

Recent Abstracts
AUA 2012 - Research presented at the American Urological Association annual meeting reveals advances in reconstructive medicine and organ engineering - Press Release May 24, 2012
AUA 2012 - Genetic variants associated with severity of lower urinary tract symptoms and prostate cancer susceptibility - Press Release May 24, 2012
AUA 2012 - The association between male pattern baldness and second to fourth finger ratio with prostate cancer - a prospective cohort study - Video Lecture May 23, 2012
AUA 2012 - A closer look at PSA testing and prostate cancer: The screening debate, genetic connection and risk in young men - Press Release May 23, 2012
AUA 2012 - Perspectives from the AUA - PSA controversy: Do the harms exceed the benefits or the benefits exceed the harms? - Video statement from William J. Catalona, MD May 23, 2012
AUA 2012 - Perspectives from the AUA - PSA controversy: Do the harms exceed the benefits or the benefits exceed the harms? - A take-away message for urologists May 23, 2012
AUA 2012 - Using social media to gauge reaction to the United States Preventive Services Task Force’s (USPSTF) report: Twitter as an investigative tool - Session Highlights May 23, 2012
AUA 2012 - Intermittent and external urinary catheterization - Slide Presentation May 23, 2012
AUA 2012 - Indwelling urinary catheters (IUC) - Slide Presentation May 23, 2012
AUA 2012 - AUA guidelines emphasizes behavioral therapies, medications to treat overactive bladder - Press Release May 23, 2012
AUA 2012 - Prostate cancer diagnosis in patients receiving unrelated urologic care: Overdiagnosis or appropriate care? - Poster May 23, 2012
AUA 2012 - New guideline calls for prompt evaluation of microscopic hematuria - Press Release May 23, 2012
AUA 2012 - Male pattern baldness may be a predictor of prostate cancer - Press Release May 23, 2012
AUA 2012 - New study suggests link between periodontitis and erectile dysfunction - Press Release May 23, 2012
AUA 2012 - Evidence suggests statin use may slow prostate growth - Press Release May 23, 2012
AUA 2012 - Androgen biosynthesis inhibition and metastatic castration-resistant prostate cancer - Exclusive Interview May 22, 2012
AUA 2012 - Group seminars are an effective and economic method of delivering patient information regarding radical prostatectomy and functional outcomes - Session Highlights May 22, 2012
AUA 2012 - The changing "landscape" of clinical T3 prostate cancer - Session Highlights May 22, 2012
AUA 2012 - Abiraterone acetate (an androgen biosynthesis inhibitor) in patients with metastatic castration-resistant prostate cancer - Slide Presentation May 22, 2012
AUA 2012 - Differences In perioperative outcomes between African American and Caucasian patients after radical prostatectomy - Session Highlights May 22, 2012
Page 506 of 524
  • Start
  • Prev
  • 501
  • 502
  • 503
  • 504
  • 505
  • 506
  • 507
  • 508
  • 509
  • 510
  • Next
  • End
  • About UroToday
  • Journals
  • Calendar
  • Editorial and Advertising Guidelines
  • Editors and Contributors
  • FAQs
  • Privacy Policy
  • Terms of Use
Follow UroToday

COPYRIGHT © 2002 - 2023 DIGITAL SCIENCE PRESS, LLC

Login

Login to update email address, newsletter preferences and use bookmarks.

  • Forgot Password?
  • Sign Up Free